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Bioactive 3D Scaffolds for the Delivery
of NGF and BDNF to Improve Nerve
Regeneration
Ana M. Sandoval-Castellanos, Frederik Claeyssens* and John W. Haycock
Department of Materials Science and Engineering, Biomaterials and Tissue Engineering Group, Kroto Research Institute, The
University of Sheffield, Sheffield, United Kingdom
Peripheral nerve injury is an important cause of disability, that can hinder significantly
sensory and motor function. The clinical gold standard for peripheral nerve repair is the use
of autografts, nevertheless, this method has limitations such as donor site morbidity. An
emerging alternative to autografts are nerve guide conduits, which are used to entubulate
the severed nerve and provide guidance for the directed regeneration of the nerve tissue.
These nerve guide conduits are less effective than autografts, and to enhance their
performance the incorporation of neurotrophins can be considered. To enable optimal
nerve regeneration, it is important to continuously stimulate neurite outgrowth by designing
a delivery system for the sustained delivery of neurotrophins. The aim of this study was to
develop a novel bioactive surface on electrospun fibres to supply a sustained release of
heparin bound NGF or BDNF electrostatically immobilised onto an amine functionalized
surface to encourage neurite outgrowth and Schwann cell migration. The bioactive surface
was characterised by XPS analysis and ELISA. To assess the effect of the bioactive surface
on electrospun fibres, primary chick embryo dorsal root ganglia were used, and neurite
outgrowth and Schwann cell migration were measured. Our results showed a significant
improvement regarding nerve regeneration, with the growth of neurites of up to 3mm in
7 days, accompanied by Schwann cells. We hypothesize that the physical guidance
provided by the fibres along the sustained delivery of NGF or BDNF created a stimulatory
environment for nerve regeneration. Our results were achieved by immobilising relatively
low concentrations of neurotrophins (1 ng/ml), which provides a promising, low-cost, and
scalable method to improve current nerve guide conduits.
Keywords: bioactive surface, NGF (nerve growth factor), BDNF (brain derived neurotrophic factor), nerve
regeneration, drug delivery, surface coating
1 INTRODUCTION
Peripheral nerve injury affects 2.8% of trauma patients (Manoukian et al., 2019), and the current
treatment is the use of autografts (Bozkurt et al., 2007). However, the limitations of using autografts
are donor site morbidity, size mismatch, and the need of at least two surgeries (Bozkurt et al., 2007).
The use of hollow tubes called nerve guide conduits (NGCs) has been studied as an alternative to aid
nerve repair (Pateman et al., 2015; Behbehani et al., 2018; Billet et al., 2019). Nevertheless, NGCs does
not support sufficient nerve regeneration in gaps longer than 20 mm (Daly et al., 2012; Pateman et al.,
2015; Manoukian et al., 2020). Therefore, the addition of topographical and chemical cues to the
NGCs has been studied to improve their performance and, hence, nerve repair.
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Research using gradients, aligned multichannels, and aligned/
random electrospun scaffolds have demonstrated that an oriented
cue can enhance neurite outgrowth as well as Schwann cell
migration (Guenard et al., 1992; Daud et al., 2012; Xie et al.,
2014; Ren et al., 2015; Bolaina-Lorenzo et al., 2016; Chwalek et al.,
2016). For example, Hurtado et al. showed that aligned nanofibers
stimulated neurite regrowth in a spinal cord injury model
(Hurtado et al., 2011). Furthermore, Kim et al. reported that
aligned fibers encouraged neurite growth in a 17 mm sciatic
injury (Kim et al., 2008). In addition, studies had stated that
the use of aligned electrospun scaffolds would be more beneficial
to use as these might resemble the extracellular matrix (ECM)
(Hurtado et al., 2011; Xie et al., 2014). Therefore, if Schwann cells
are stimulated to migrate (Maniwa et al., 2003; Heermann and
Schwab, 2013), these cells and the aligned electrospun scaffold
would create a regenerative environment to aid nerve repair
(Horne et al., 2010; Daud et al., 2012). Although studies using
aligned fibrous scaffold have stimulated neurite outgrowth, the
level of nerve regeneration produced is still not sufficient (for
example, 2.1 ± 0.33 mm, 1.4 mm), as the critical nerve gap in
humans is 4 cm, and in rats is 1.5 cm (Wang et al., 2010; Kaplan
et al., 2015; Behbehani et al., 2018). An interesting route to further
enable nerve repair is to include chemical cues in the NGCs to
provide a long term permissive environment (Chwalek et al.,
2016; Liu et al., 2018).
Nerve growth factor (NGF) and brain derived neurotrophic
factor (BDNF) are known to encourage neurite outgrowth and
Schwann cell migration after nerve injury (Frostick et al., 1998;
Fine et al., 2002; Deister and Schmidt, 2006; Matsumoto et al.,
2007; Horne et al., 2010; Santos et al., 2016; Yi et al., 2016).
Nevertheless, their use in the clinic, and in different approaches, is
limited by their half-life, loss of their biological activity and that
they might not reach the injury site (DeYoung et al., 2004; Pfister
et al., 2008; Liu et al., 2019). Hence, research has been conducted
to design and fabricate systems for the delivery of growth factors,
which would protect growth factors from degradation and
denaturation (Zeng et al., 2014). Growth factors can be
incorporated onto electrospun scaffolds by covalent binding,
electrostatic interactions, coatings, encapsulation and addition
of microspheres, emulsion and coaxial electrospinning (Dinis
et al., 2014; Liu et al., 2019). With the exception of surface
functionalisation via either covalent binding or electrostatic
interactions, all the aforementioned techniques compromise
the integrity and functionality of the growth factors due to
their use of organic solvents or crosslinking agents (Kuo and
Huang, 2012; Whitehead et al., 2018; Ikegami and Ijima, 2020).
The effectivity of covalent binding of growth factors has been
demonstrated before, for example, Guex et al. covalently
immobilised vascular endothelial growth factor (VEGF) onto
an oxygen plasma treated scaffold and promoted endothelial
cell proliferation (Guex et al., 2014). Nevertheless, covalent
binding might result in the loss of bioactivity or denaturation
of the growth factor (Willerth and Sakiyama-Elbert, 2007;
Robinson et al., 2008; Hajimiri et al., 2015).
A second approach is to use electrostatic interactions to bind
growth factors. Indeed, heparin has been used to immobilise
growth factors by electrostatic interactions (Robinson et al., 2008;
Robinson et al., 2012). For example, Robinson et al. bound
osteoprotogerin or tissue inhibitor of metalloproteinases 3 to
heparin and studied their release (Robinson et al., 2012). Heparin
is highly negatively charged, so to bind heparin to a surface by
electrostatic interactions, this surface needs to have a positive
charge. Plasma treatment and deposition is commonly used to
add charged functional groups to a surface, changing the
properties of the surface (Fine et al., 2002; Robinson et al.,
2012; Recek et al., 2013). For example, air and oxygen plasma
treatment are used to make polymeric surfaces hydrophilic
(Recek et al., 2013), and typically renders these surfaces
negatively charged (Lehocký, 2003). To produce positively
charged surfaces in a polymeric substrate, amine based plasma
deposition can be used, for example, by using allylamine to add
positively charged amine (NH2
+) functional groups to a surface
(Lee et al., 1994; Fine et al., 2002; Robinson et al., 2012). Hence,
the surfaces functionalised by plasma deposited NH2
+ groups
bind heparin, which consequently binds growth factors such as
NGF, BDNF or a mixture of NGF and BDNF.
Previously, we showed how a bioactive surface, which was
used as a delivery system of growth factors, was fabricated by
using electrostatic interactions (Crawford-Corrie et al., 2017;
Sandoval-Castellanos et al., 2020). Furthermore, we
demonstrated that bioactive surfaces composed of NH2
+ +
Heparin + Immobilised NGF, NH2
+ + Heparin + Immobilised
BDNF, and NH2
+ + Heparin + Immobilised NGF plus BDNF
encouraged neurite outgrowth of chick embryo dorsal root
ganglia (DRG) on 2D surfaces (Sandoval-Castellanos et al., 2020).
Therefore, the novelty of this study was to assess the efficiency
of this bioactive surface coating onto 3D scaffolds, as the
combined action of chemical cues and contact guidance is
envisage to further encourage and enhance neurite outgrowth
in comparison to 2D surfaces (Roach et al., 2007). Moreover, it is
critical to design and scale up this bioactive surface so it can be
easily translated into clinical use. Polycaprolactone (PCL) was the
chosen material to fabricate these 3D scaffolds due to its
bioresorbable properties and for its slow degradation rate,
which is up to 4 years (Lam et al., 2008). These properties are
advantageous for our bioactive surface, as PCL could sustain the
bioactivity of the surface without compromising the structure of
the scaffold. Also, PCL is an FDA-approved polyester, which has
been used previously for drug delivery and for nerve repair
applications (Woodruff and Hutmacher, 2010; Daud et al.,
2012; Nectow et al., 2012; Shahriari et al., 2017).
Therefore, electrospinning was used to fabricate a novel 3D
bioactive scaffold for nerve regeneration, made from aligned PCL
microfibres. Then, NH2
+ functional groups were added to the
scaffold by plasma deposition. Thereafter, heparin was added by
passive conjugation and finally, NGF, BDNF or a combination of
NGF plus BDNF were immobilised at different concentrations,
including 1 pg/ml and 1 ng/ml, which at the best of our
knowledge, have not been used before (Li et al., 2017; Ikegami
and Ijima, 2020). Hence, PCL + NH2
+ + Heparin + Immobilised
NGF scaffolds, PCL + NH2
+ + Heparin + Immobilised BDNF
scaffolds, and PCL + NH2
+ + Heparin + Immobilised NGF plus
BDNF scaffolds were fabricated. The bioactive surfaces were
characterised by XPS and ELISA to confirm the incorporation
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of NH2
+, heparin and NGF or BDNF. Moreover, to study the
potential of the bioactive surface on the PCL electrospun
scaffolds, DRG were seeded on the scaffolds, and neurite
outgrowth and Schwann cell migration were assessed.
2 MATERIALS AND METHODS
2.1 Fabrication of Polycaprolactone
Electrospun Scaffolds
A 20% w/v solution of polycaprolactone (PCL, Mn. 80,000 g/mol,
Cat. No. 440744, Sigma-Aldrich, United Kingdom) was prepared
in a glass container with dichloromethane (DCM, Cat. No. D/
1850/17, Fisher Scientific, United Kingdom) as a solvent. The
20% PCL solution was loaded in a 1 ml syringe (Cat. No. 309628
Beckton Dickinson, BD, United Kingdom). A dispensing blunt
needle of 20-gauge, (1 inch long, Cat. No. 8001098, Fisnar,
United States) was attached to the syringe and then placed in
the syringe pump (AL 1000-220, World Precision Instruments,
WPI, United Kingdom). A high voltage supply (Genvolt,
United Kingdom) was used to set the required voltage. A flow
rate of 6 ml/h, voltage of 16–18 kV, distance of 20 cm, and speed
of collector of 2,000 rpm were set to obtain an aligned PCL
electrospun scaffold.
2.2 Plasma Deposition
2.2.1 Allylamine Plasma Deposition
PCL electrospun scaffolds were placed inside a glass vessel
(10.5 cm diameter, 42.0 cm length). Then, the vacuum pump
was turned on to evacuate the glass vessel to 8 × 10−3mBar. Then,
the pressure was adjusted to 2.2 × 10−2 mBar by opening the inlet
valve, allowing allylamine monomer (Cat. No. 145831, Aldrich,
United Kingdom) into the glass vessel. Thereafter, the radio
frequency generator (13.56 MHz) was turned on, and the
output power adjusted to 10W. The allylamine plasma
deposition process, which creates a blue discharge glow, was
left for 10 min. Thereafter, the radiofrequency generator was
turned off, the inlet valve was closed, and the scaffolds were
left inside the glass vessel for 5 min to allow any remaining NH2
+
to bind onto the surface. Then, the scaffolds were placed inside a
petri dish to avoid any contamination.
2.2.2 Air Plasma Treatment
PCL electrospun scaffolds were modified with air plasma to be
used as positive controls. PCL electrospun scaffolds were placed
inside the glass vessel and the vacuum pump was turned on to
evacuate the glass vessel to 7 × 10−2mBar. Then, the pressure was
adjusted to 1.8 × 10−1 mBar, allowing air into the glass vessel.
Thereafter, the radio frequency generator was turned on, and the
output power adjusted to 25W. The air plasma deposition
process was left for 2 min.
2.3 Heparin Conjugation to
Polycaprolactone + NH2
+ Scaffolds
A solution of heparin sodium salt (Cat. No. H3393, Sigma,
United Kingdom) was prepared at a concentration of 50 µg/
ml. This heparin solution was added to the PCL + NH2
+
scaffolds and incubated overnight at room temperature. After
incubation, the heparin solution was discarded. Heparin
conjugation was done 24 h after plasma treatment.
2.4 Immobilisation of Nerve Growth Factor,
Brain Derived Neurotrophic Factor and
Nerve Growth Factor Plus Brain Derived
Neurotrophic Factor to Polycaprolactone +
NH2
+ + Heparin Scaffolds
NGF (Cat. No. 556-NG/CF, R&D systems, United States), BDNF
(Cat. No. 248-BD/CF, R&D systems, United States) and a
combination of both (NGF plus BDNF) were immobilised onto
PCL + NH2
+ + Heparin scaffolds. NGF and BDNF, alone, were
prepared at concentrations of 1 pg/ml, 1 ng/ml, 10 ng/ml, 100 ng/
ml, and 1 µg/ml. NGF plus BDNF were prepared at concentrations
of 1 and 100 ng/ml. Each solution was added onto PCL + NH2
+ +
Heparin scaffolds and incubated for 5 h at room temperature.
Then, the solutions were discarded. PCL + NH2
+ + Heparin +
Immobilised NGF scaffolds, PCL + NH2
+ + Heparin +
Immobilised BDNF scaffolds, and PCL + NH2
+ + Heparin +
Immobilised NGF plus BDNF scaffolds were now fabricated.
2.5 Scanning Electron Microscopy Analysis
of Polycaprolactone Electrospun Scaffolds
Scanning ElectronMicroscopy (SEM) was used to obtain images of
the PCL electrospun scaffolds to measure the diameter the fibres,
before and after plasma deposition. Samples of the PCL electrospun
scaffold were cut in 1 cm × 1 cm squares and placed on carbon
adhesive tabs (Leit adhesive carbon tabs, Cat. No. AGG3347N,
Agar Scientific, United Kingdom). To improve the quality of the
image, all samples of PCL electrospun scaffolds were gold-coated
(SC 500A, Emscope) before imaging with a field emission SEM
(Sorby Centre, FE SEM JSM-6500F, Jeol Ltd., United Kingdom).
The voltage used was 10 kV and the spot size was 3.5 nm.
ImageJ 1.52a software (National Institutes of Health,
United States) (Schneider et al., 2012) was used to measure the
diameter of the fibres in the PCL electrospun scaffold, before and
after plasma deposition. Three tests were run independently, and
three PCL electrospun scaffolds chosen as samples. Three images
were taken, and 10 PCL fibres were measured, per image.
2.6 X-Ray Photoelectron Spectroscopy
Analysis of Polycaprolactone + NH2
+ +
Heparin Scaffolds
After 24 h of fabricating the bioactive surface, X-ray Photoelectron
Spectroscopy (XPS) analysis was performed at the Sheffield Surface
Analysis Centre (The University of Sheffield, United Kingdom).
PCL scaffolds were interrogated to determine surface elemental
composition (survey scans), nitrogen scans (N 1s), and sulphur
scans (S 2p) using a Kratos Ultra instrument with a
monochromated aluminium source (1,486.6 eV). Elemental
survey scans were collected between 1,200 and 0 eV binding
energy, 160 eV pass energy and 1 eV intervals. High resolution
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N 1s and S 2p scans were collected at 40 eV pass energy and 0.1 eV
intervals. Data was processed and analysed using CasaXPS (version
2.3.19 PR 1.0, Casa Software Ltd).
2.7 Release Profile of Nerve Growth Factor
and Brain Derived Neurotrophic Factor for
21days
The release of NGF and BDNF for 21 days was characterised by
ELISA. NGF and BDNF were immobilised at 1 ng/ml following
the protocol described in Immobilisation of Nerve Growth Factor,
Brain Derived Neurotrophic Factor and Nerve Growth Factor Plus
Brain Derived Neurotrophic Factor to Polycaprolactone + NH2
+ +
Heparin Scaffolds. Samples were incubated with phosphate
buffered saline (PBS; Cat. No. BR0014G, Oxoid,
United Kingdom) at 37°C. Samples were taken at 1 h, 24 h,
48 h, 168 h (7 days), 240 h (10 days), 336 h (14 days), 408 h
(17 days), and 504 h (21 days) and stored at −20°C for later
quantification, following the manufacturer’s instructions (NGF
and BDNF kit, Cat. No. DY556, DY248, DY008, R&D systems,
United States). Four samples were interrogated per test condition.
Two independent tests were performed.
2.8 In vitro Evaluation Using Chick Embryo
Dorsal Root Ganglia
Fertilised brown chicken eggs (Henry Stewart & Co. Ltd.,
United Kingdom) were incubated at 37.5°C and 50–70%
humidity for 12 days (E12). Thereafter, day 12 eggs were
opened in a biological safety cabinet to collect the E12
embryo, which was cleaned, and organs were removed [in
compliance with UK Home Office Animals (Scientific
Procedures) Act 1986 and definition of chicken as a Protected
Animal from E14]. DRG were dissected under a dissecting
microscope (Wild M3Z, Switzerland) and any remains of the
root were cut. DRG were seeded at a density of one per scaffold.
DRG were cultured on PCL + NH2
+ + Heparin + Immobilised
NGF scaffolds, PCL + NH2
+ + Heparin + Immobilised BDNF
scaffolds, and PCL + NH2
+ + Heparin + Immobilised NGF plus
BDNF scaffolds with Dulbecco’s modified Eagle’s medium
(DMEM; Cat. No. D6546, Sigma, United Kingdom) plus 10%
(v/v) fetal bovine serum (FBS, Cat. No. P30-3,306, PAN Biotech,
Germany), 1% (v/v) L-glutamine (Cat. No. G7513, Sigma,
United Kingdom), 1% (v/v) penicillin/streptomycin (P/S; Cat.
No. P0781, Sigma, United Kingdom), 0.25% (v/v) amphotericin B
(Cat. No. A2942, Sigma, United Kingdom). DRG that were
seeded on PCL scaffolds, PCL + NH2
+ scaffolds, and PCL +
NH2
+ + Heparin scaffolds were culture with DMEM
supplemented with 10% FBS, 1% P/S, 1% L-glutamine, 0.25%
amphotericin B, and 1 µg/ml of NGF or BDNF. Scaffolds with
DRG were cultured for 7 days at 37°C and 5% CO2.
2.9 Immunolabelling of Dorsal Root Ganglia:
β-III Tubulin and S100β
Immunolabelling was performed for β-III tubulin protein, to
identify neurons and measure neurite outgrowth and S100-β
protein to identify Schwann cells. Samples were fixed using
3.7% v/v paraformaldehyde (PFA, Cat. No. 158127, Sigma,
United Kingdom). Then, 0.1% v/v Triton X-100 (Cat. No.
BP151, Sigma, United Kingdom) with 3% w/v bovine serum
albumin solution (BSA, Cat. No. A7030, Sigma, United Kingdom)
was added to the samples and incubated for 1 h at room
temperature. Primary antibodies, anti-β-III tubulin (1:1,000,
Cat. No. ab7751, RRID: AB_306045, Abcam,
United Kingdom) and anti-S100β (1:400, Cat. No. Z5116,
RRID: AB_2622233, Dako, United States) in 1% w/v BSA
solution were added to the samples and incubated overnight at
4°C. Then, the solution was discarded and secondary antibodies,
Alexa Fluor 488 goat anti-mouse, and Alexa Fluor 546 goat anti-
rabbit (1:400, Cat. No. A-11001 and A-11010, Life technologies,
United States) in 1% BSA solution was added and incubated for
3 h at 4°C. The samples were rinsed one time with PBS and then
stored at 4°C with PBS. Secondary antibody control groups were
imaged to assure that antibodies did not bind nonspecifically
(Supplementary Figure S1).
2.10 Lightsheet Microscopy
Lightsheet microscopy was used to obtain images of the DRG
seeded on bioactive scaffolds. Z.1 lightsheet microscope (Carl
Zeiss AG, Germany) and ZEN imaging software (Zen 9.2.8.54,
Carl Zeiss, Germany) were used to obtain these images. Samples
were cut longitudinally and then mounted in 1% agarose solution
(w/v, in dH2O, Cat. No. A9414, Sigma-Aldrich, United Kingdom)
inside glass capillaries (diameter 2.15 mm, Cat. No. 701999, Carl
Zeiss AG, Germany). Samples were localised and positioned in
front of the objective. The objective used was a Zeiss W Plan-
Apochromat 10 × /N.A. 0.5 for detection and two Zeiss LSFM 5 ×
/N.A. 0.1 for illumination. Alexa Fluor-488 and Alexa Fluor-546
were imaged using excitation and emission wavelengths of λex 
488 nm/λem  550 nm (short band filter), and λex  561 nm/λem 
545–590 nm (band pass filter) respectively. For each sample,
various fields of view (longitudinally) were taken to capture all
neurite outgrowth and Schwann cell migration. Each field of view
was imaged in z-stack.
The z-stack was combined to produce a maximum projection
intensity image using ZEN lite software (Carl Zeiss, Germany).
Then, the maximum projection intensity images were put
together using the stitching tool in ImageJ 1.52a software
(Preibisch et al., 2009). The straight tool in ImageJ 1.52a
software (Schneider et al., 2012) was used to measure neurite
outgrowth and Schwann cell migration. Neurites (neurite bundle)
were measured from the end of the DRG body to the tip of the
neurite. Schwann cells were measured from the end of the DRG
body to the last Schwann cell (the one most distal from the DRG).
Two images were taken per sample. Three independent tests were
performed. Each condition was tested in triplicate.
2.11 Statistical Analysis
Analysis of variance (ANOVA) with Tukey multiple comparison
test was performed to analyse statistical difference among the
different conditions using GraphPad Prism 8.2.0 software
(United States). A p value of <0.05 was used to indicate if
differences in data were significant.
Frontiers in Materials | www.frontiersin.org October 2021 | Volume 8 | Article 7346834
Sandoval-Castellanos et al. Bioactive Scaffolds for Nerve Regeneration
3 RESULTS
3.1 Polycaprolactone Fibre Morphology and
Diameter Before and After Plasma
Deposition Measured via Scanning Electron
Microscopy
The fibre diameter of the electrospun scaffold is a critical
parameter for in vitro neuronal cell migration as highlighted
in our previous papers (Daud et al., 2012; Behbehani et al., 2018).
The fibre diameter of the non-treated PCL scaffold was measured
and compared to the plasma treated scaffolds, either after air
plasma treatment or allylamine plasma treatment or deposition.
This was mainly to identify if PCL fibres had undergone
significant changes after plasma deposition. Figure 1 presents
representative SEM figures of the fibres before and after
treatment. The PCL fibres show a wavy surface micro-texture
both before and after surface treatment, at a 0.5–1 µm length
scale. This texture is likely due to solvent evaporation during the
electrospinning process (Yazgan et al., 2017; Xue et al., 2019).
Additionally, the diameter of PCL fibres (Figure 1A), PCL air
plasma treated fibres (Figure 1B) and PCL NH2
+
fibres
(Figure 1C) was measured to be 8 ± 0.7, 7.7 ± 0.9, and 8.1 ±
0.9 µm, respectively. There was no significant difference
between these values, as shown in Figure 1D.
3.2 X-Ray Photoelectron Spectroscopy
Analysis of Bioactive Polycaprolactone
Scaffolds
XPS analysis was performed to confirm the presence of amine
NH2
+ functional groups and heparin (through sulphur detection)
in PCL scaffolds. Table 1 shows the percentage of atomic
concentration of PCL scaffolds (Figure 2A), PCL Air scaffolds
(Figure 2B), PCL +NH2
+ scaffolds (Figure 2C), and PCL +NH2
+
+ Heparin scaffolds (Figure 2D). Survey scans of the samples
showed that nitrogen was introduced after allylamine plasma
deposition and that sulphur was detected in PCL + NH2
+ +
Heparin scaffolds, confirming the successful adsorption of
heparin on this scaffold. Carbon and oxygen peaks were
observed at 285 and 532 eV, respectively. After allylamine
plasma deposition, a nitrogen peak at 400 eV was expected to
appear on the PCL NH2
+ scaffolds, which XPS analysis
confirmed. In addition, a sulphur peak was detected at 168 eV
FIGURE 1 | PCL electrospun fibres morphology. (A) PCL fibre before plasma deposition; (B) PCL fibre after air plasma deposition; (C) PCL fibre after allylamine
plasma deposition; (D) Bar chart showing fibre diameter of PCL fibres before and after plasma deposition, with no significant differences (One-way ANOVA). Scale bar
 10 µm.
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in the PCL + NH2
+ + Heparin scaffolds, confirming the presence
of heparin on the scaffolds.
N 1s scans of PCL + NH2
+ scaffolds, and PCL + NH2
+ +
Heparin scaffold, revealed that nitrogen was incorporated to the
films. Moreover, two peaks were identified, one at 399 eV,
indicating C-N, and a peak at 401 eV, which was attributed to
NH2
+ (Begum et al., 2017). However, overall nitrogen content
decreased from 21.2 to 7.5%, after heparin attachment, this could
indicate that nitrogen might have been lost after incubation step
of heparin or after rinsing step (Dehili et al., 2006). On the other
hand, the drop in percentage of nitrogen content can also be
attributed to strong binding of heparin to the plasma polymerised
allylamine coating. Heparin (with atomic formula
C12H19NO20S3) contains only three at %N (excluding H), and
a concentration of heparin within the analysis depth of XPS
(typically 10 nm) decrease the nitrogen content. Interestingly, the
amount of sulphur detected by the survey scan was 0.2 at %, this
confirms the electrostatic binding of heparin to the surface. The
amount of sulphur on the surface is in line with our previously
reported surface concentration of allylamine-heparin coating in
tissue culture plastic (Sandoval-Castellanos et al., 2020).
Additionally, this is also in line with the figure reported of 0.5
at %S on the surface by layer-by-layer deposition of polyethylene-
heparin on a polylactic acid surface (Gigliobianco et al., 2015).
In addition, S 2p scan of PCL + NH2
+ + Heparin scaffolds
revealed two peaks, which were consistent with sulphur present in
heparin (OSO3 and NSO3) (John et al., 1992; Kristensen et al.,
2003; Kristensen et al., 2006). These two peaks correspond to the
spin orbit split of S 2p, S 2p3/2 (168.2 eV) and S 2p1/2 (169.3 eV).
Hence, heparin was adsorbed successfully to the PCL NH2
+ +
Heparin scaffold.
3.3 Nerve Growth Factor and Brain Derived
Neurotrophic Factor Release From
Bioactive Surfaces
After heparin immobilisation, the surface was treated with NGF
or BDNF. ELISA detected the release of NGF and BDNF, for
TABLE 1 | Percentage of atomic concentration of PCL scaffolds, PCL Air scaffolds, PCL NH2
+ scaffolds and PCL NH2
+ + Heparin scaffolds obtained from XPS analysis
survey scans. Si content was also detected on the surface.
Sample Survey scan: percentage atomic concentration %
O N C S
PCL scaffolds 23.4 ± 0.7 0 ± 0 70.2 ± 2.4 0 ± 0
PCL air plasma treated scaffolds 26.9 ± 0.4 0 ± 0 72.4 ± 0.4 0 ± 0
PCL + NH2
+ scaffolds 23.1 ± 2.7 21.2 ± 11.7 54.2 ± 8.3 0 ± 0
PCL + NH2
+ + Heparin scaffolds 26.0 ± 1.2 7.5 ± 1.1 64.7 ± 2.0 0.2 ± 0
FIGURE 2 | XPS survey scans of (A) PCL scaffold; (B) PCL air treated scaffold (PCL Air scaffold); (C) PCL + NH2
+ scaffold; (D) PCL+ NH2
+ + Heparin scaffold.
Carbon was detected at 285 eV, oxygen at 532 eV, nitrogen at 400 eV, and sulphur at 168 eV.
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21 days, from bioactive surfaces NH2
+ + Heparin when NGF and
BDNF were immobilised, and NH2
+ scaffolds. Figure 3 shows the
sustained released of NGF and BDNF for 21 days. In contrast,
when NGF was added to NH2
+ surface only, NGF release was
observed at 1, 24, 48, and 168 h. After the 168 h time point, no
release of NGF was observed. Furthermore, from the control
(NGF in PBS), active NGF was not detected after 24 h. Similarly,
when BDNF was added to NH2
+ surface only, BDNF release was
observed at 1, 24, and 48 h. After the 48 h time point, no release of
BDNF was observed. Furthermore, from the control, active
BDNF was not detected after 168 h. This indicates that the
immobilisation strategy via binding of the growth factors to
heparin allows for a sustained release of active growth factors
over an extended time period.
3.4 Dorsal Root Ganglia Neurite Outgrowth
and Schwann Cell Migration
Neurite outgrowth of DRG and Schwann cell migration were
measured and averaged to obtain average neurite length and
average Schwann cell migration of DRG cultured on seven
different surface treated scaffolds: 1) PCL scaffolds, 2) PCL air
plasma treated scaffolds, 3) PCL + NH2
+ scaffolds, 4) PCL +
NH2
+ + Heparin scaffolds, 5) PCL + NH2
+ + Heparin +
Immobilised NGF scaffolds, 6) PCL + NH2
+ + Heparin +
Immobilised BDNF scaffolds and 7) PCL + NH2
+ + Heparin +
Immobilised NGF plus BDNF scaffolds.
The longest average neurite length, from the NGF group, was
3,041 ± 843 µm for DRG cultured on PCL + NH2
+ + Heparin +
Immobilised NGF at 1 ng/ml. The shortest average neurite length
was 226 ± 177 µm for DRG cultured on PCL scaffolds
(Figure 4A). The longest Schwann cell migration was 2,718 ±
911 µm when DRG were seeded on immobilised NGF at 1 ng/
ml. The shortest migration length of Schwann cells was 270 ±
185 µm when DRG were cultured on PCL scaffolds (Figure 4B).
The longest average neurite length from the BDNF group was
1,536 ± 762 µm for when DRG were cultured on PCL + NH2
+ +
Heparin + Immobilised BDNF at 1 ng/ml (Figure 4C). The
longest Schwann cell migration was 1,614 ± 543 µm when
DRG were seeded on PCL + NH2
+ + Heparin + Immobilised
BDNF at 10 ng/ml (Figure 4D).
The longest average neurite length and Schwann cell
migration from NGF plus BDNF group were 1,816 ± 583, and
1,974 ± 708 µm, respectively, when DRG were cultured on PCL
air plasma treated scaffolds with NGF plus BDNF at 1 µg/ml in
solution in culture medium (Figures 4E,F). Interestingly, these
results also showed that the co-immobilisation of NGF and
BDNF did not have any accumulative effect and that this
combination did not stimulate the growth of longer neurites.
Overall, these results suggested that the delivery of NGF at a
relative low concentration of 1 ng/ml as an immobilised
neurotrophin from PCL + NH2
+ + Heparin + Immobilised
NGF scaffolds, encouraged the growth of longer neurites, in
comparison to the other control and test scaffolds. This
delivery system, using NGF at 1 ng/ml would be an
appropriate candidate for further studies regarding nerve repair.
These cell culture results were further investigated with an
in vitro organ culture via placing DRG onto the scaffold. Figure 5
shows representative lightsheet images of DRG grown on 1) PCL,
2) PCL air plasma treated, 3) PCL + NH2
+, 4) PCL + NH2
+ +
Heparin, without growth factor, 5) PCL + NH2
+ + Heparin +
Immobilised NGF at 1 ng/ml, 6) PCL + NH2
+ + Heparin +
Immobilised BDNF at 1 ng/ml, and 7) PCL air plasma treated
with NGF plus BDNF at 1 µg/ml in culture medium. Neurites
were stained for β-III tubulin (green), and Schwann cells were
stained for S100β (red). Growing neurites are usually
accompanied by migrating Schwann cells, hence, co-
localisation of both β-III tubulin and S100β was expected. This
co-localisation is observed in yellow.
4 DISCUSSION
We reported on the successful fabrication of bioactive 3D
scaffolds for the delivery of NGF, BDNF, or NGF plus BDNF
for enhancing nerve repair. PCL fibrous scaffolds were fabricated
by electrospinning and fibre diameter was measured using SEM.
NH2
+ functional groups were added by plasma deposition, and
heparin was added to fabricate the bioactive surface NH2
+ +
Heparin. Furthermore, NGF and BDNF were successfully
immobilised onto the surface via binding to the
FIGURE 3 | NGF and BDNF release from NH2
+ + Heparin. (A) NH2
+ +
Heparin + Immobilised NGF 1 ng/ml (circles), and NH2
+ (squares) at different
time points, from 1 to 504 h (21 days). NGF at 1 ng/ml in solution in PBS was
used as a control (triangles). (B) BDNF release from NH2
+ + Heparin +
Immobilised BDNF 1 ng/ml (circles), and NH2
+ (squares) at different time
points, from 1 to 504 h (21 days). BDNF at 1 ng/ml in solution was used as a
control (triangles).
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FIGURE 4 | Average neurite length and Schwann cell migration of DRG when cultured on PCL scaffolds, PCL Air scaffolds, PCL + NH2
+ scaffolds, PCL + NH2
+ +
Heparin scaffolds, and PCL + NH2
+ + Heparin + Immobilised neurotrophin for 7 days. (A) Average neurite length and (B) Schwann cell migration for when DRG were
cultured with NGF. NGF was immobilised on the bioactive surfaces at 1 pg/ml, 1 ng/ml, 10 ng/ml, 100 ng/ml, and 1 µg/ml. NGF was added in solution at 1 µg/ml with
control surfaces. (C) Average neurite length and (D) Schwann cell migration for when DRG were cultured with BDNF. BDNF was immobilised on the bioactive
surfaces at 1 pg/ml, 1 ng/ml, 10 ng/ml, 100 ng/ml, and 1 µg/ml. BDNF was added in solution at 1 µg/ml with control surfaces. (E) Average neurite length and (F)
Schwann cell migration for when DRG were cultured with NGF plus BDNF. NGF plus BDNF were immobilised on the bioactive surfaces at 1 and 100 ng/ml. NGF plus
BDNF were added in solution at 1 µg/ml with control surfaces. One-way ANOVA statistical analysis was performed with Tukey procedure of multiple comparisons *p <
0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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electrostatically immobilised heparin. The addition of NH2
+ and
heparin was confirmed by XPS. Moreover, the addition of NGF or
BDNF and its release were confirmed by ELISA. Culture of
primary chick embryo DRG was used to assess the effects of
the bioactive scaffolds. Furthermore, cell viability was assessed on
the bioactive surface by MTS assay (Supplementary Figure S2),
where no decrease in metabolic activity was observed.
Research has been conducted to study how scaffolds with
aligned structures can improve neurite outgrowth to aid nerve
repair. Daud et al. fabricated PCL electrospun scaffold (8 µm fibre
diameter) and seeded DRG on them to evaluate neurite
outgrowth and Schwann cell migration. This study showed
that, after 10 days in culture, Schwann cells migrated 1.9 mm
and that neurite outgrowth was 1.6 mm (Daud et al., 2012).
Additionally, Bozkurt et al. fabricated a parallel-oriented pores
scaffold using collagen and evaluated neurite outgrowth from
DRG. This study revealed that maximum and average neurite
outgrowth, after 21 days in culture, was 1,496, and 756 µm
respectively (Bozkurt et al., 2007). Moreover, Behbehani et al.
fabricated PCL fibres and introduced them inside a polyethylene
glycol conduit. Neurite outgrowth and Schwann cell migration
from DRG seeded on this construct were 2.1 and 2.2 mm
respectively, after 21 days in culture (Behbehani et al., 2018).
Furthermore, Hurtado et al. fabricated random and aligned poly-
L-lactic acid (PLLA) fibres and measured neurite length
developed by DRG after 5 days in culture. This study showed
FIGURE 5 | DRG seeded on control PCL bioactive scaffolds: PCL scaffold, PCL air treated scaffold (PCL Air scaffold), PCL + NH2
+ scaffold, PCL + NH2
+ + Heparin
scaffold, PCL + NH2
+ + Heparin + Immobilised NGF at 1 ng/ml scaffold, PCL + NH2
+ + Heparin + Immobilised BDNF at 1 ng/ml scaffold, and PCL air treated scaffold
(PCL Air scaffold) with NGF plus BDNF at 1 µg/ml in culture medium. B-III tubulin protein in neurites stained in green. S100β of Schwann cells stained in red. Merged
channels are yellow, representing the co-localisation of growing neurites and Schwann cells. Scale bar  500 µm.
Frontiers in Materials | www.frontiersin.org October 2021 | Volume 8 | Article 7346839
Sandoval-Castellanos et al. Bioactive Scaffolds for Nerve Regeneration
that random PLLA fibres encouraged neurite growth of ca. 900
and 800 µm (maximum and average neurite length respectively),
whereas aligned PLLA fibres promoted neurite growth of ca.
1,700 and 1,500 µm (maximum and average neurite length
respectively) (Hurtado et al., 2011).
These studies showed that even if different materials can be
used as guidance, and the alignment and fibre diameter and
density can be controlled, these features alone are not sufficient to
induce rapid cell attachment and neurite outgrowth, which is
needed for nerve repair (Ramsey et al., 1984; Meek and Coert,
2008; Kehoe et al., 2012). Therefore, it is important to improve
these strategies to encourage the growth of longer neurites.
Plasma deposition technique is usually used to add functional
groups onto surfaces of materials to modify surface properties,
such as surface energy and wettability (Chan et al., 1996; Recek
et al., 2013). Indeed, hydrophobic surfaces can be produced via
using fluorine containing compounds for plasma treatment, while
hydrophilic surfaces can be obtained via using oxygen or nitrogen
containing plasmas (Chan et al., 1996; Recek et al., 2013). Plasma
treatment and polymerisation has been used to improve cell
adhesion, proliferation, and to add functional groups to
further modify the surface of a material. Furthermore,
functional groups have been introduced by plasma
polymerisation onto the surface of a material to bind growth
factors, thus allowing the delivery of the growth factor in a
sustained manner to encourage a specific cell response. For
example, Guex et al. functionalised PCL fibrous scaffolds via
plasma treatment with carbon dioxide, ethene, and argon. Then,
VEGF was covalently immobilised onto the activated PCL
scaffold (Guex et al., 2014). This study showed that
proliferation of endothelial cells was improved when VEGF
was immobilised on the surface (Guex et al., 2014).
Furthermore, Shen et al. evaluated that adhesion and
proliferation of fibroblast was improved by the immobilisation
of basic fibroblast growth factor (bFGF) on carbon dioxide
plasma treated poly(lactide-co-glycolyde) (PLGA) films (Shen
et al., 2008).
Therefore, allylamine plasma deposition was performed to
fabricate bioactive surfaces of NH2
+ + Heparin + Immobilised
NGF/BDNF/NGF plus BDNF on PCL electrospun scaffolds, to
translate this technology for future applications into medical
devices to aid nerve repair. Allylamine monomer was used
during plasma deposition to add amine functional groups onto
PCL fibres. As amine functional groups, NH2
+, have a positive
charge (Robinson et al., 2012), heparin, a negatively charged
molecule, will be bound to amine by electrostatic interactions
(Robinson et al., 2012). Although the presence of NH2
+ was
detected on the bioactive surface by XPS analysis, how to control
the deposition of NH2
+ bound to the surface, and how different
plasma deposition parameters might change the amount of NH2
+,
is yet to be studied in future work.
Crystal violet adhesion assay was performed to evaluate any
changes in cell adhesion. The results showed that PCL + NH2
+
and PCL + NH2
+ + Heparin scaffolds increased attachment by 76
and 121% in comparison to positive control tissue culture plastic
(TCP). In contrast, PCL scaffolds decreased cell attachment by
18% in comparison to TCP (Supplementary Figure S3).
NGF and BDNF were immobilised on this bioactive scaffold
PCL + NH2
+ + Heparin. ELISA was performed to confirm the
presence of NGF and BDNF on the fabricated NH2
+ + Heparin
scaffold. Moreover, ELISA was also performed to assess the
delivery of NGF and BDNF from the bioactive surface within
21 days.
The results from ELISA revealed the controlled release of NGF
and BDNF from the surface for up to 21 days. Moreover, it
showed that a sustained delivery of both growth factors, with no
burst released, was achieved. When NGF and BDNF were bound
to NH2
+ scaffold, NGF and BDNF release was seen within 7 days
and 48 h respectively. After that, no growth factor release was
observed. This could be due to a very low quantity of growth
factors bound to the surface by weak interactions, the degradation
of NGF and BDNF because they were not established (Lam et al.,
2001). These findings are supported by Kim et al. who found that
microspheres loaded with heparin bound significantly more
bFGF and NGF than microspheres without heparin (Kim
et al., 2015). Moreover, Johnson et al. also incorporated
heparin into hydrogels to stabilise both NGF and BDNF
(Johnson et al., 2015). This suggests that NH2
+ + Heparin
bioactive scaffold is an appropriate delivery system for the
release of NGF and BDNF for 21 days, as it can bind higher
quantities of growth factors and stabilise them.
Currently, there is not a defined standard release profile of
growth factors to obtain a desired cellular response. This cellular
response should be evaluated for each delivery system. For nerve
repair, there are two desirable outcomes: encouragement neurite
growth and Schwann cell migration. Schwann cells create an
environment to stimulate neurite growth and formation.
Moreover, neurotrophic factors are produced, by neurite
outgrowth and Schwann cell stimulation, to aid both neurite
outgrowth and Schwann cell migration (Frostick et al., 1998;
Cheng and Zochodne, 2002; Daud et al., 2012; Shakhbazau et al.,
2012; Ren et al., 2015; Santos et al., 2016; Yi et al., 2016). Hence,
both neurite outgrowth and Schwann cell migration were
assessed in this study.
As NGF and BDNF are known to encourage neurite
outgrowth in DRG (Matsumoto et al., 2007), both growth
factors were immobilised, alone and in combination, on the
bioactive surface NH2
+ + Heparin described herein. This
bioactive surface was added to PCL electrospun scaffolds, as
the fibres would direct neurite growth and Schwann cell
migration. The results showed that PCL + NH2
+ + Heparin +
Immobilised NGF 1 ng/ml encouraged the longest average
neurite length and furthest Schwan cell migration (3,041 ± 843
and 2,718 ± 911 µm respectively, for 7 days in culture). PCL +
NH2
+ + Heparin + Immobilised BDNF 1 ng/ml also stimulated
neurite outgrowth and Schwann cell migration (1,536 ± 762 µm,
1,571 ± 828 µm respectively), but not as high as the ones
encouraged by immobilised NGF. Interestingly, PCL + NH2
+
+ Heparin + Immobilised NGF plus BDNF did not promote
comparable neurite outgrowth (1,107 ± 456 µm) and Schwann
cell migration (1,169 ± 538 µm) when compared to immobilised
NGF 1 ng/ml and immobilised BDNF 1 ng/ml.
Growth factors, specifically neurotrophins, are crucial to
enhance neurite outgrowth and Schwann cell migration.
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However, due to the half-life of the growth factors, it is essential to
design a system which stabilises and delivers growth factors with
the purpose of extending the half-life of growth factors, and hence
reducing the amount required, and to maintain a sustained
delivery of these during the healing process. Liu et al.
fabricated micropatterned channels scaffold with
polydimethyl-siloxane (PDMS) (Liu et al., 2018). Then, DRG
were co-cultured with Schwann cells for 21 days to study neurite
outgrowth. Moreover, Liu et al. encapsulated NGF (50 µg/ml) in a
collagen gel, which then was incorporated into one of the sides of
the PDMS channels. Neurite outgrowth was ca. 2,000 and ca.
2,500 µm respectively for both DRG seeded with Schwann cells
and collagen-loaded NGF (Liu et al., 2018).
Additionally, Dinis et al. added NGF and CNTF (1 µg/ml and
100 ng/ml respectively) into a 9% silk fibroin in polyethylene
oxide to produce electrospun aligned fibres. When DRG were
cultured for 5 days on NGF and CNTF silk fibres, neurite
outgrowth was of ca. 1,000–1,500 µm (Dinis et al., 2014). This
study partially supported the findings herein, where the use of two
growth factors did not have an accumulative effect on neurite
outgrowth. Nevertheless, its effect was better than when one of
the growth factors was used individually, in this case, CNTF.
Furthermore, Whitehead et al. electrospun aligned methacrylated
hyaluronic acid with PLGA microspheres, which contained NGF
at 100 µg/ml (Whitehead et al., 2018). This study revealed that,
after culturing DRG for 5 days, 40–80% of NGFwas released from
the microspheres, encouraging neurite outgrowth of ca.
1,500–2000 µm (Whitehead et al., 2018).
In contrast, the bioactive scaffold reported herein, PCL +
NH2
+ + Heparin + Immobilised NGF 1 ng/ml encouraged
3,041 ± 843 µm neurite growth and 2,718 ± 911 µm Schwann
cell migration from DRG cultured for 7 days. This outcome
showed that our bioactive scaffold used as a delivery system
optimised the use of NGF and achieved a greater outcome than
the ones reported in current literature. PCL + NH2
+ + Heparin +
Immobilised BDNF also stimulated neurite outgrowth, but its
growth was not as long as the neurite outgrowth reached when
immobilising NGF. Moreover, our results showed that PCL +
NH2
+ +Heparin + Immobilised NGF plus BDNF, although it also
promoted neurite outgrowth, it might not be the best
combination of growth factors to co-immobilise to obtain a
significant neurite outgrowth and Schwann cell migration.
In comparison to our previous work (Sandoval-Castellanos
et al., 2020), adding the bioactive surface NH2
+ + Heparin +
Immobilised NGF/BDNF onto PCL electrospun scaffolds
significantly stimulated neurite outgrowth and Schwann cell
migration. This might be due to the combination of two
elements: 1) topographical cues (PCL electrospun scaffold) as
these encourage enhanced neurite outgrowth (Kim et al., 2008);
and 2) chemical cues (bioactive surface) as it is known that by
adjusting the surface properties, cell behaviour, such as adhesion,
proliferation, and migration, is enhanced (Ren et al., 2015; Min
et al., 2021). Therefore, combining PCL electrospun scaffold with
the bioactive surface NH2
+ +Heparin + Immobilised NGF/BDNF
could create a permissive environment, which would mimic up to
a certain extent the ECM, to further improve neurite growth and
guidance, as well as Schwann cell migration to aid nerve repair.
NGF and BDNF immobilised alone are promising
approaches to encourage neurite growth and Schwann cell
migration after injury. The reason why DRG were stimulated
significantly by immobilised NGF more than BDNF might be
related to the number of high affinity receptors present in the
DRG (Kimpinski et al., 1997; Maniwa et al., 2003). It is known
that in an adult DRG, 40–50% of the receptors are tyrosine
kinase receptor (Trk) A, 5–30% are TrkB, and 10–20% are TrkC
(Kimpinski et al., 1997). As NGF binds to TrkA and BDNF
binds to TrkB, the possibility to stimulate a response with NGF
was higher. Moreover, NGF and BDNF also bind to the low
affinity receptor p75NTR, therefore, NGF and BDNF would be
also competing for this receptor, suggesting that an equilibrium
of interactions between TrkA and p75NTR or TrkB and p75NTR
(Kimpinski et al., 1997) should be achieved to maximise neurite
length and Schwann cell migration. In addition, immobilisation
of NGF plus BDNF did not show any accumulative effect. In
fact, when DRG were seeded on PCL + NH2
+ + Heparin +
Immobilised NGF plus BDNF 1 ng/ml and PCL + NH2
+ +
Heparin + Immobilised NGF plus BDNF 100 ng/ml, average
neurite length was 1,107 ± 456 and 867 ± 524 µm respectively.
Interestingly, both values are lower than when DRG were
seeded with either NGF or BDNF alone at 1 and 100 ng/ml.
A possible explanation for this outcome is related to the
receptors TrkA, TrkB and p75NTR. As mentioned before, an
equilibrium of interactions between TrkA/B and p75NTR is
required to maximise neurite length. However, as both NGF
and BDNF are present, an equilibrium between TrkA, TrkB and
p75NTR was expected. Nevertheless, from our results we
hypothesised that the receptors were saturated, and the
pathway that enables neurite outgrowth was hindered. This
needs to be tested further, to clarify why the cumulative effect
was not observed.
As mentioned before, sensory neurons (DRG) express more
TrkA receptors, whereas motor neurons express more TrkB
receptors (Frostick et al., 1998; Min et al., 2021). The
advantage of this application is that PCL + NH2
+ + Heparin
+ Immobilised NGF uses a relatively low concentration of NGF
(1 ng/ml) to encourage longer neurite length. Additionally, it
could potentially stimulate the growth of longer neurites in a
sensory nerve, encouraging nerve repair. However, a limitation
of this application is that PCL + NH2
+ + Heparin +
Immobilised BDNF and PCL + NH2
+ + Heparin +
Immobilised NGF plus BDNF did not stimulate longer
neurite outgrowth in sensory neurons. Nevertheless, these
scaffolds should be tested further with a motor neuron
model and with sensory neurons in combination with
motor neurons to fully evaluate the potential of the
bioactive surface when both motor and sensory neurons
are used.
5 CONCLUSION
The bioactive surfaces NH2
+ + Heparin + Immobilised NGF,
NH2
+ + Heparin + Immobilised BDNF, and NH2
+ + Heparin +
Immobilised NGF plus BDNF were successfully added onto PCL
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electrospun scaffolds. XPS analysis confirmed the presence of
NH2
+ and heparin on the scaffolds. Moreover, ELISA revealed
that NGF and BDNF were immobilised on the surface and that a
sustained release of both NGF and BDNF was maintained for
21 days. This was a major step, as the bioactive surfaces were
successfully added onto PCL electrospun scaffold, representing a
step closer to translating this technology into an NGC for future
clinical use.
Most importantly, PCL + NH2
+ + Heparin + Immobilised
NGF at 1 ng/ml encouraged the average neurite outgrowth
3,041 ± 843 μm, average maximum neurite length 3,869 ±
1,092 μm, and Schwann cell migration length 2,718 ± 911 µm.
To the best of our knowledge, these outcomes have the highest
neurite length to NGF ratio found in the literature. This suggests
that by immobilising a relatively low concentration of NGF, 1 ng/
ml, onto the bioactive surface NH2
+ + Heparin on PCL
electrospun scaffolds, the growth of longer neurites and the
further migration of Schwann cells can be achieved. Therefore,
these scaffolds PCL + NH2
+ + Heparin + Immobilised NGF at
1 ng/ml are a promising approach to improve current NGCs to
aid nerve repair.
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